Crescendo Biologics Limited
Crescendo Biologics Limited, a pioneering biopharmaceutical company based in Great Britain, focuses on the development of innovative therapeutic solutions. Founded in 2008, Crescendo has established itself in the biotechnology industry, specialising in the creation of unique, fully human monoclonal antibodies and biologics. With a strong emphasis on its proprietary VH domain technology, the company aims to address unmet medical needs in oncology and autoimmune diseases. Crescendo's commitment to advancing biologics has positioned it as a notable player in the market, with significant achievements in drug development and strategic partnerships. As it continues to expand its operational reach, Crescendo Biologics remains dedicated to delivering cutting-edge therapies that enhance patient outcomes.
DitchCarbon Score
How does Crescendo Biologics Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Crescendo Biologics Limited's score of 23 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Crescendo Biologics Limited's reported carbon emissions
Crescendo Biologics Limited, headquartered in Great Britain, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company may be engaged in various climate commitments and initiatives typical within the biotechnology sector, focusing on sustainability and reducing environmental impact. As the industry increasingly prioritises climate action, Crescendo Biologics Limited may align with broader trends aimed at achieving net-zero emissions and enhancing environmental responsibility. Further information on their specific commitments or initiatives would be necessary to provide a comprehensive overview.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Crescendo Biologics Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
